Severe osteoporosis is defined by two criteria occurring together: a bone density T-score of -2.5 or lower, plus at least one fragility fracture. This distinguishes it from standard osteoporosis, which is diagnosed on bone density alone. Some clinical guidelines use an even stricter threshold, classifying osteoporosis as severe when the T-score drops below -3.0 regardless of fracture history, or when the T-score is below -1.5 with multiple vertebral fractures.
How T-Scores Define Each Stage
A T-score compares your bone density to that of a healthy adult between 25 and 35 years old of the same sex and ethnicity. The result is expressed as a standard deviation, essentially how far your bones have drifted from peak density. Normal bone density is a T-score of -1.0 or above. Osteopenia (mild bone thinning) falls between -1.0 and -2.5. Osteoporosis begins at -2.5 or below.
Severe, or “established,” osteoporosis adds a clinical event to that number. A T-score of -2.5 paired with a fracture from minimal trauma confirms that the bone loss has already progressed to the point of structural failure. In practice, many clinicians also flag a T-score below -3.0 as severe even without a documented fracture, because the fracture risk at that level is extremely high.
There is also a Z-score, which compares your bone density to others your own age rather than to young adults. Z-scores are mainly used in premenopausal women and younger men. For diagnosing osteoporosis and determining severity in postmenopausal women, the T-score is the standard measurement.
What Counts as a Fragility Fracture
A fragility fracture is any break caused by low-energy trauma, meaning a force that would not normally fracture healthy bone. The classic example is a fall from standing height or less. Sneezing, bending to pick something up, or bumping into furniture can be enough when bones are severely weakened.
The most common sites are the spine, hip, wrist, and upper arm. Fractures can also occur in the pelvis, ribs, and upper shin. Hip and spinal fractures are considered the most serious, both because of the disability they cause and their effect on survival. A meta-analysis of hip fracture outcomes found that women had a 5-fold increase and men an almost 8-fold increase in the likelihood of death within the first three months compared to people of the same age and sex who hadn’t fractured. One-year mortality after hip fracture ranges from 14% to 58% depending on the patient’s overall health and the care they receive.
Spinal fractures can be harder to recognize. Many vertebral compression fractures happen silently, without a single dramatic moment of injury. They reveal themselves gradually through height loss and a rounding of the upper back.
Physical Signs That Suggest Severity
Height loss is one of the most practical warning signs. Losing 3 centimeters (roughly 1.2 inches) or more from your tallest adult height raises the likelihood of an underlying vertebral fracture. At 4 centimeters of loss, about half of postmenopausal women in one large study had a confirmed osteoporotic fracture. If you’ve noticed your pants getting longer, your ribcage sitting closer to your hips, or a visible forward curve in your upper back, those are worth mentioning to your doctor.
That forward curve, called kyphosis, becomes clinically significant when the curvature of the thoracic spine reaches 50 degrees or more on imaging. At that point it can compress the lungs and stomach, making it harder to breathe deeply or eat full meals. It also shifts your center of gravity forward, increasing the risk of falls and further fractures.
How Fracture Risk Is Estimated
Bone density alone doesn’t capture the full picture. A tool called FRAX estimates your 10-year probability of a major fracture based on age, sex, weight, smoking status, alcohol use, family history of hip fracture, and other risk factors. It can be calculated with or without a bone density scan.
In the United States and Canada, a 10-year probability of 20% or higher for a major osteoporotic fracture, or 3% or higher for a hip fracture specifically, is the threshold at which treatment guidelines recommend medication. People with a prior fragility fracture are generally placed directly into the high-risk category without needing to run the calculation first, because the fracture itself is strong evidence that bone strength has already failed.
Why Severe Cases Are Treated Differently
Standard osteoporosis is typically treated with medications that slow bone breakdown. These are the first choice for someone newly diagnosed who hasn’t yet fractured. They work by reducing the rate at which old bone is removed, giving the body more time to maintain its existing structure.
Severe osteoporosis often calls for a different class of medication: bone-building drugs that actively stimulate new bone formation rather than just slowing loss. These are reserved for people with T-scores below -3.0, those who have fractured despite being on treatment, or those who continue losing bone density on standard therapy. The goal shifts from preservation to rebuilding, because slowing the rate of loss is no longer sufficient when the skeleton has already weakened to the point of fracturing.
These bone-building therapies are typically used for a limited window, often one to two years, and then followed by a maintenance medication. The sequencing matters: starting with a bone-building drug and then switching to a maintenance drug produces better long-term bone density gains than the reverse order. For people with T-scores below -3.0, referral to a bone health specialist is common, because the treatment plan requires more careful monitoring and adjustment.
How Bone Loss Is Monitored Over Time
Bone density scans are the primary tracking tool, but they only capture a snapshot. Blood and urine tests can measure the pace of bone turnover in real time. One common marker reflects how quickly bone is being broken down, while another reflects how quickly new bone is being formed. In severe osteoporosis, the breakdown marker is often elevated relative to the formation marker, indicating the skeleton is losing ground faster than it can rebuild.
These markers are also useful for checking whether treatment is working. A significant drop in the breakdown marker within a few months of starting medication suggests the drug is doing its job, well before a follow-up bone density scan would show measurable change. That early feedback can be reassuring when you’re managing a condition where improvement is slow and the stakes of another fracture are high.
The Cascade Fracture Problem
The most dangerous feature of severe osteoporosis is the fracture cascade. Once one vertebral fracture occurs, the altered mechanics of the spine concentrate more force on the neighboring vertebrae, which are equally fragile. This creates a chain reaction where each fracture increases the likelihood of the next. The same principle applies elsewhere in the skeleton: a wrist fracture signals that the hip and spine are vulnerable too.
This is why the distinction between osteoporosis and severe osteoporosis matters so much clinically. A T-score of -2.7 without a fracture is a warning. A T-score of -2.7 with a fractured vertebra is an urgent signal that the next fracture may be months away, and that more aggressive treatment is warranted now rather than later.